From pluripotent stem cells to T cells

Slides:



Advertisements
Similar presentations
Oxidative stress and hypoxia in normal and leukemic stem cells Ugo Testa, Catherine Labbaye, Germana Castelli, Elvira Pelosi Experimental Hematology Volume.
Advertisements

GSK3β inhibition activates the CDX/HOX pathway and promotes hemogenic endothelial progenitor differentiation from human pluripotent stem cells Kenji Kitajima,
Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors  Sara Charmsaz, Andrew M. Scott,
Genetic Engineering and Manufacturing of Hematopoietic Stem Cells
Susanne Wingert, Michael A. Rieger  Experimental Hematology 
Constitutively Active β-Catenin Confers Multilineage Differentiation Potential on Lymphoid and Myeloid Progenitors  Yoshihiro Baba, Karla P. Garrett,
Ling Guo, Robert C.H. Zhao, Yaojiong Wu  Experimental Hematology 
Nishitha M. Reddy, Olalekan Oluwole, John P. Greer, Brian G
Lotte Bruens, Hugo J.G. Snippert  Cell Stem Cell 
Cassie J. Clarke, Tessa L. Holyoake  Experimental Hematology 
Upgrading from iMac to iMicro
281. Rapid Generation of Induced Pluripotent Stem Cells (iPSCs) from the Urine of a Patient with Duchenne Muscular Dystrophy    Molecular Therapy  Volume.
HLA-A*0201+ Plasmacytoid Dendritic Cells Provide a Cell-Based Immunotherapy for Melanoma Patients  Caroline Aspord, Marie-Therese Leccia, Dimitri Salameire,
Direct Conversion of Skin Cells into Blood: Alchemy or Science?
Advances in basic and clinical immunology in 2011
The potential of umbilical cord blood multipotent stem cells for nonhematopoietic tissue and cell regeneration  Carmella van de Ven, Daniel Collins, M.
Miki Ando, Hiromitsu Nakauchi  Experimental Hematology 
Nat. Rev. Cardiol. doi: /nrcardio
Induced pluripotent stem cell technology: A window for studying the pathogenesis of acquired aplastic anemia and possible applications  Mahmoud I. Elbadry,
Sca-1 is an early-response target of histone deacetylase inhibitors and marks hematopoietic cells with enhanced function  Marta A. Walasek, Leonid V.
Kinetics and symmetry of divisions of hematopoietic stem cells
Cerebral Organoids in a Dish: Progress and Prospects
Getting blood from bone: An emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their niche  Yusuke.
Marking of definitive HSC precursors in E7. 5–E8
Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors  Sara Charmsaz, Andrew M. Scott,
Quiescence regulators for hematopoietic stem cell
Reiner Schulte, Nicola K. Wilson, Janine C. M
Christine V. Ichim, Džana D
Early production of human neutrophils and platelets posttransplant is severely compromised by growth factor exposure  Paul H. Miller, David J.H.F. Knapp,
HLA-A*0201+ Plasmacytoid Dendritic Cells Provide a Cell-Based Immunotherapy for Melanoma Patients  Caroline Aspord, Marie-Therese Leccia, Dimitri Salameire,
Induced pluripotent stem cell modeling of malignant hematopoiesis
Xiaoou Zhou, Malcolm K. Brenner  Experimental Hematology 
Volume 2, Issue 6, Pages (December 2012)
Christopher E. Schmitt, Carlos O. Lizama, Ann C. Zovein 
Arterial identity of hemogenic endothelium: a key to unlock definitive hematopoietic commitment in human pluripotent stem cell cultures  Igor I. Slukvin,
Engineering Hematopoietic Stem Cells: Lessons from Development
Eun-ju Lee, Pankaj Godara, David Haylock  Experimental Hematology 
Susanne Wingert, Michael A. Rieger  Experimental Hematology 
Experimental Hematology
A dual role of Erk signaling in embryonic stem cells
Volume 6, Issue 2, Pages (February 2016)
Volume 21, Issue 1, Pages (July 2017)
Experimental Hematology
Old Meets New: The Interaction Between Innate and Adaptive Immunity
Volume 12, Issue 1, Pages (January 2013)
Franco Locatelli, Damiano Rondelli, G.Roberto Burgio 
Application of small molecule CHIR99021 leads to the loss of hemangioblast progenitor and increased hematopoiesis of human pluripotent stem cells  Yekaterina.
Peter Karagiannis, Shinya Yamanaka, Megumu K. Saito 
Impact of HDAC inhibitors on dendritic cell functions
Moonjung Jung, Cynthia E Dunbar, Thomas Winkler  Molecular Therapy 
Thrombocytopenia with absent radii (TAR) syndrome: from hemopoietic progenitor to mesenchymal stromal cell disease?  Laura Bonsi, Cosetta Marchionni,
Inside This Issue Experimental Hematology
Volume 24, Issue 1, Pages (January 2006)
Sietske T. Bakker, Emmanuelle Passegué  Experimental Hematology 
Volume 6, Issue 5, Pages (May 2016)
From Skin to Blood: A New Member Joins the iClub
Geneviève Despars, Helen C O'Neill  Experimental Hematology 
Kinase signaling and targeted therapy for primary myelofibrosis
25 Years of Epidermal Stem Cell Research
Hematopoietic potential of HEP from patient-specific iPSC may be reduced. Hematopoietic potential of HEP from patient-specific iPSC may be reduced. (A)
Thomas M. Schmitt, Juan Carlos Zúñiga-Pflücker  Immunity 
Volume 16, Issue 4, Pages (April 2015)
Erratum Experimental Hematology
Stem cell biology and the plasticity polemic
Releasing the Brakes on Cancer Immunotherapy
Mesp1 at the Heart of Mesoderm Lineage Specification
Pediatric leukemia: Moving toward more accurate models
Sensing Bad: Are Co-stimulatory CAR-Expressing γδ T Cells Safer?
Cellular Alchemy and the Golden Age of Reprogramming
Memoirs of a Reincarnated T Cell
Presentation transcript:

From pluripotent stem cells to T cells Amélie Montel-Hagen, Gay M. Crooks  Experimental Hematology  Volume 71, Pages 24-31 (March 2019) DOI: 10.1016/j.exphem.2018.12.001 Copyright © 2019 ISEH -- Society for Hematology and Stem Cells Terms and Conditions

Figure 1 Schema of current approaches for T-cell differentiation from hPSCs. (A) Common models of T-cell differentiation from hPSCs consist of a multistep process with the specification of mesoderm by either generating EBs or cocultivating PSCs on OP9 stromal lines in the presence of morphogens. Culture conditions are then changed to favor hematoendothelial induction. The CD34+ hematopoietic cells generated from OP9 cocultures, EBs, or hematopoietic zones are then isolated and replated onto OP9-DLL1 or DLL4 stromal monolayers for T-cell differentiation. (B) In the ATO model, mesoderm specification is initiated from PSCs to produce EMPs that are then aggregated with MS5-DLL4 in 3D organoids placed at a liquid–air interface. Hematopoietic specification and T-cell commitment and differentiation into mature naïve CD3+ T cells (either CD8(ab)+ or CD4+) are then induced by simple medium changes. Experimental Hematology 2019 71, 24-31DOI: (10.1016/j.exphem.2018.12.001) Copyright © 2019 ISEH -- Society for Hematology and Stem Cells Terms and Conditions

Figure 2 Schemas for the generation of antigen-specific T-lineage cells from PSCs for immunotherapy. (A) Lentiviral expression of CAR in PSCs, followed by the differentiation model using EB generation and coculture on OP9-DLL1 monolayers, produces innate-like CAR T cells. This model can be applied to any PSCs including T-iPSCs. (B) iPSCs derived from a clone of T cells (T-iPSCs) expressing a specific TCR and differentiated using multistep monolayer coculture on OP9 and OP9-DL1 stromal cells produce CD4+CD8aa DP cells, which, when isolated and activated with anti-CD3, produce CD8ab T cells that express the original TCR of the T-cell clone. (C) Lentiviral expression of a class I-restricted TCR (in this case specific for the tumor antigen NYESO-1) TCR in PSCs, followed by the production of EMPs and the generation of ATOs as shown in Figure 1, leads directly to the production of conventional mature NY-ESO TCR+ CD8ab T cells that possess antigen-specific cytotoxicity. Experimental Hematology 2019 71, 24-31DOI: (10.1016/j.exphem.2018.12.001) Copyright © 2019 ISEH -- Society for Hematology and Stem Cells Terms and Conditions